Scintilla Pharmaceuticals, Inc. Jointly Administered under 23-90085.
11
Christopher M. Lopez
02/13/2023
10/17/2023
Yes
v
| PlnDue, DsclsDue, COMPLX, DEFmaillist, JNTADMN |
Assigned to: Bankruptcy Judge Christopher M. Lopez Chapter 11 Voluntary Asset |
|
Debtor Scintilla Pharmaceuticals, Inc.
7 Switchbud Place Suite 192-513 PO Box 513 The Woodlands, TX 77380 MONTGOMERY-TX Tax ID / EIN: 47-4207956 |
represented by |
Matthew D Cavenaugh
Jackson Walker LLP 1401 McKinney Street Ste 1900 Houston, TX 77010 713-752-4200 Email: mcavenaugh@jw.com |
U.S. Trustee US Trustee
Office of the US Trustee 515 Rusk Ave Ste 3516 Houston, TX 77002 |
| Date Filed | # | Docket Text |
|---|---|---|
| 10/17/2023 | Judge Christopher M. Lopez added to case. Involvement of Judge David R Jones Terminated (RobbieWestmoreland) (Entered: 10/17/2023) | |
| 10/16/2023 | 11 | Objection and Reservation of Rights to Cure / Executory Contracts. Filed by Fisher Scientific Company, LLC (Attachments: # 1 Affidavit Certificate of Service) (Manne, Beverly) (Entered: 10/16/2023) |
| 06/02/2023 | 10 | Notice of Certification Pursuant to Order Compelling Brokerag Fiirms' Compliance with Various Regulatory Requirements. Filed by Texas Treasury Safekeeping Trust Company (FrancesCarbia) |
| 05/22/2023 | 9 | Response Certification. Filed by HSBC Bank USA, National Association (Peterson, Anne) (Entered: 05/22/2023) |
| 05/12/2023 | 8 | Notice of Appearance and Request for Notice Filed by Ryan S Killian Filed by on behalf of Mayo Foundation for Medical Education and Research, Mayo Clinic, Inc. (Killian, Ryan) (Entered: 05/12/2023) |
| 02/15/2023 | 7 | BNC Certificate of Mailing. (Related document(s):3 Order for Joint Administration) No. of Notices: 1. Notice Date 02/15/2023. (Admin.) (Entered: 02/15/2023) |
| 02/14/2023 | 6 | No Creditor Mailing List (MayraMarquez) (Entered: 02/14/2023) |
| 02/14/2023 | 5 | An order directing joint administration of this case has been entered by the Court in accordance with FED. R. BANKR. P. 1015(b). The docket in Case No. 23-90085 should be consulted for all matters affecting this case. All future pleadings shall be filed in and all subsequent docket entries shall be made in the Lead Case. Interested parties are directed to the order directing joint administration for further information. (AlbertAlonzo) (Entered: 02/14/2023) |
| 02/14/2023 | Receipt of Voluntary Petition (Chapter 11)( 23-90084) [misc,volp11] (1738.00) Filing Fee. Receipt number A24200012. Fee amount $1738.00. (U.S. Treasury) (Entered: 02/14/2023) | |
| 02/13/2023 | 4 | Notice of Appearance and Request for Notice Filed by Patricia Baron Tomasco Filed by on behalf of NantCell, Inc. and Immunotherapy NANTibody LLC (Tomasco, Patricia) (Entered: 02/13/2023) |